Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein

BACKGROUND: Heptaplatin is a new platinum derivative with anticancer activity against various cancer cell lines, including cisplatin-resistant cancer cell lines (Cancer Chemother Pharmacol 1995; 35: 441). METHODS: Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Cheol-Hee, Cha, Yoon-Jung, An, Chun-San, Kim, Kyung-Jong, Kim, Kweon-Cheon, Moon, Sung-Pyo, Lee, Zang Hee, Min, Young-Don
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC533863/
https://www.ncbi.nlm.nih.gov/pubmed/15494073
http://dx.doi.org/10.1186/1475-2867-4-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC533863/
https://www.ncbi.nlm.nih.gov/pubmed/15494073
http://dx.doi.org/10.1186/1475-2867-4-6

Ejemplares similares